Astera Labs (NASDAQ:ALAB) Shares Down 8.8% – What’s Next?

Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) traded down 8.8% during trading on Monday. The company traded as low as $201.00 and last traded at $202.34. 4,514,914 shares traded hands during trading, a decline of 12% from the average daily volume of 5,138,362 shares. The stock had previously closed at $221.83.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. BMO Capital Markets assumed coverage on shares of Astera Labs in a report on Thursday, November 5th. They issued an “outperform” rating and a $375.00 target price on the stock. UBS Group lowered their price objective on Astera Labs from $300.00 to $290.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 4th. Barclays boosted their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Finally, Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $320.85.

View Our Latest Report on Astera Labs

Astera Labs Stock Down 8.8%

The stock has a market capitalization of $35.36 billion, a P/E ratio of 80.61 and a beta of 3.86. The firm has a 50 day simple moving average of $294.27 and a two-hundred day simple moving average of $257.09.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.13. The company had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. Astera Labs’s revenue for the quarter was up 153.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 earnings per share. On average, research analysts predict that Astera Labs, Inc. will post 2.99 earnings per share for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the sale, the director owned 3,309 shares of the company’s stock, valued at $909,842.64. The trade was a 73.10% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 220,497 shares of company stock worth $62,043,303. Corporate insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of large investors have recently made changes to their positions in ALAB. Greenleaf Trust increased its position in shares of Astera Labs by 1.8% during the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after acquiring an additional 36 shares during the period. Parkside Financial Bank & Trust increased its holdings in Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after purchasing an additional 41 shares during the period. Integrated Advisors Network LLC raised its position in Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock valued at $350,000 after purchasing an additional 45 shares in the last quarter. L2 Asset Management LLC raised its position in Astera Labs by 5.4% in the 3rd quarter. L2 Asset Management LLC now owns 910 shares of the company’s stock valued at $324,000 after purchasing an additional 47 shares in the last quarter. Finally, Interchange Capital Partners LLC boosted its stake in shares of Astera Labs by 4.4% in the 3rd quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock valued at $423,000 after buying an additional 50 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Read More

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.